MedTrace Logo

The Differential Effects of Diabetes Therapy on Inflammation

NCT02150707 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2016-05-18

No results posted yet for this study

Summary

This study aims to determine if different diabetes treatments have different effects on inflammation; in particular, kidney inflammation. This type of inflammation is common in people with diabetes, and can lead to kidney failure. This study will investigate the effect of different types of diabetes treatment on kidney inflammation. This will help us to decide if certain types of medicine should be preferred in people with evidence of inflammation in their kidneys, as this may help prevent major complications including kidney failure.

Conditions

Interventions

DRUG

Dipeptidyl-Peptidase IV Inhibitors

Dipeptidyl-Peptidase IV Inhibitors to treat hyperglycaemia

DRUG

Glucagon-Like Peptide 1

Glucagon-Like Peptide 1 to treat hyperglycaemia

Sponsors & Collaborators

Principal Investigators

  • Donal O'Shea, MD FRCPI · University College Dublin

  • Carel W le Roux, PhD MB FRCP · University College Dublin

  • Mensud Hatunic, MD MRCPI · University College Dublin

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02150707 on ClinicalTrials.gov